241 related articles for article (PubMed ID: 10458226)
1. Elements of informed consent for hormone replacement therapy in patients with diagnosed breast cancer.
Chlebowski RT; McTiernan A
J Clin Oncol; 1999 Jan; 17(1):130-42. PubMed ID: 10458226
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
3. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
4. The oncologic impact of hormone replacement therapy in premenopausal breast cancer survivors: A systematic review.
Wang Y; Lewin N; Qaoud Y; Rajaee AN; Scheer AS
Breast; 2018 Aug; 40():123-130. PubMed ID: 29763858
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy and breast cancer: revisiting the issues.
DeGregorio MW; Taras TL
J Am Pharm Assoc (Wash); 1998; 38(6):738-44; quiz 744-6. PubMed ID: 9861792
[TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
Burger H
Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
[TBL] [Abstract][Full Text] [Related]
7. Is HRT justified for symptom management in women at higher risk of developing breast cancer?
Rippy L; Marsden J
Climacteric; 2006 Dec; 9(6):404-15. PubMed ID: 17085372
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial.
Fahlén M; Fornander T; Johansson H; Johansson U; Rutqvist LE; Wilking N; von Schoultz E
Eur J Cancer; 2013 Jan; 49(1):52-9. PubMed ID: 22892060
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy in women with breast cancer. Do the risks outweigh the benefits?
Roy JA; Sawka CA; Pritchard KI
J Clin Oncol; 1996 Mar; 14(3):997-1006. PubMed ID: 8622051
[TBL] [Abstract][Full Text] [Related]
10. Hormone replacement therapy in women with a history of breast cancer.
Ylikorkala O; Metsä-Heikkilä M
Gynecol Endocrinol; 2002 Dec; 16(6):469-78. PubMed ID: 12626034
[TBL] [Abstract][Full Text] [Related]
11. The risks and benefits of hormonal replacement therapy in healthy women and in breast cancer survivors.
Welnicka-Jaskiewicz M; Jassem J
Cancer Treat Rev; 2003 Oct; 29(5):355-61. PubMed ID: 12972354
[TBL] [Abstract][Full Text] [Related]
12. Management of postmenopausal osteoporosis and the prevention of fractures.
Gambacciani M; Levancini M
Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
[TBL] [Abstract][Full Text] [Related]
13. Beliefs about breast cancer risk and use of postmenopausal hormone replacement therapy.
Armstrong K; Popik S; Guerra C; Ubel PA
Med Decis Making; 2000; 20(3):308-13. PubMed ID: 10929853
[TBL] [Abstract][Full Text] [Related]
14. Recent concerns surrounding HRT.
Armitage M; Nooney J; Evans S
Clin Endocrinol (Oxf); 2003 Aug; 59(2):145-55. PubMed ID: 12864790
[TBL] [Abstract][Full Text] [Related]
15. Evidence from randomised trials on the long-term effects of hormone replacement therapy.
Beral V; Banks E; Reeves G
Lancet; 2002 Sep; 360(9337):942-4. PubMed ID: 12354487
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy in breast cancer survivors.
Xydakis AM; Sakkas EG; Mastorakos G
Ann N Y Acad Sci; 2006 Dec; 1092():349-60. PubMed ID: 17308160
[TBL] [Abstract][Full Text] [Related]
17. Clinical practice guidelines for the care and treatment of breast cancer: 14. The role of hormone replacement therapy in women with a previous diagnosis of breast cancer.
Pritchard KI; Khan H; Levine M;
CMAJ; 2002 Apr; 166(8):1017-22. PubMed ID: 12002977
[TBL] [Abstract][Full Text] [Related]
18. The long-term risks and benefits of hormone replacement therapy.
Hillard TC; Whitcroft S; Ellerington MC; Whitehead MI
J Clin Pharm Ther; 1991 Aug; 16(4):231-45. PubMed ID: 1939402
[TBL] [Abstract][Full Text] [Related]
19. Vascular effects of aromatase inhibitors: data from clinical trials.
Howell A; Cuzick J
J Steroid Biochem Mol Biol; 2005 May; 95(1-5):143-9. PubMed ID: 15936188
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of raloxifene and hormone replacement therapy in postmenopausal women: impact of breast cancer risk.
Armstrong K; Chen TM; Albert D; Randall TC; Schwartz JS
Obstet Gynecol; 2001 Dec; 98(6):996-1003. PubMed ID: 11755544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]